An interdisciplinary approach to the management of oncohematological patients with immunodeficiency: clinical cases. A review

LG Babicheva, AV Luntsov… - Journal of Modern …, 2023 - modernonco.orscience.ru
Immunodeficiency occurs when one or more immune system components do not function
properly, resulting in the body's inability to resist mostly infectious agents. Most cases of …

Common variable immunodeficiency, hypogammaglobulinemia, and specific antibody deficiency

HK Lehman, P Sandhu - … and Secondary Immunodeficiency: A Case-Based …, 2021 - Springer
Antibody deficiencies are a group of primary immune deficiencies caused by defects in B-
cell development, B-cell activation, or antibody synthesis. Defects discussed in this chapter …

Сучасні підходи до вакцинації в дітей з різними варіантами первинних та вторинних імунодефіцитів (огляд літератури)

AN Lesovskaya - Ukrainian Journal of Perinatology and …, 2023 - ujpp.med-expert.com.ua
Chronic disease and immunosuppression increase the risk of vaccine-preventable
infections, complications, and mortality from infectious diseases. Safe vaccination and …

[HTML][HTML] Hipogammaglobulinemia crónica postrasplante de precursores hematopoyéticos y su tratamiento con gammaglobulina subcutánea en pacientes pediátricos

SS Font, L López-Granados, L Sisinni, JVS Berna… - Anales de …, 2022 - Elsevier
Introducción La hipogammaglobulinemia en los primeros meses postrasplante de
progenitores hematopoyéticos (TPH) es común en pacientes pediátricos. Durante esta fase …

Challenges in Infection Management in the Immunocompromised Patient: A Case Report

A Barbosa Ribeiro, C Rebelo, L Patrão - Best 2022 Clinical Cases in …, 2023 - Springer
Immunosuppressive agents carry significant risk of infection of both typical and atypical
microorganisms with increased mortality. Pneumocystis jirovecii and Cytomegalovirus are …

[HTML][HTML] Immunoglobulin Therapy in the 21st Century–the Dark Side of the Moon

A Farrugia, M Visentini, I Quinti - Frontiers in Immunology, 2015 - frontiersin.org
Since its widespread introduction in the early 1980s, immunoglobulin therapy (IG) has been
extensively investigated to understand its mechanism of action and clinical benefits …

[PDF][PDF] Hipogammaglobulinemia secundaria en adultos: cohorte retrospectiva

E Angarola - 2022 - trovare.hospitalitaliano.org.ar
Introducción: la hipogammaglobulinemia genera propensión a eventos infecciosos,
principalmente sinopulmonares por bacterias extracelulares capsuladas. El uso de …

[PDF][PDF] 3.2 Verbrauchsmaterialien

P mit Filter, HO Biozym - Charakterisierung der humoralen adaptiven …, 2021 - d-nb.info
E. faecalis, 05632 Bi 2 05, 30 E. faecium, 34726 Bi 09, 90 E. coli, 42794 TSB 3 05, 38 P.
aeruginosa, 25542 Bi 22, 10 S. marcescens, 12255 Bi 11, 30 S. aureus, USA300 Δ spa Bi …

[PDF][PDF] Role of Staphylococcus aureus cytolysins in human pul-monary infection

E Kabak - 2022 - phaidra.univie.ac.at
ABSTRACT S. aureus is one of the most notorious bacterial species causing a range of
potentially lifethreatening diseases, including ventilator-associated pneumonia (VAP), a …

[HTML][HTML] The development and implementation of a subcutaneous immunoglobulin (SCIG) program at CancerCare Manitoba

E Streu - Canadian OnCOlOgy nursing JOurnal, 2016 - ncbi.nlm.nih.gov
138 Volume 26, Issue 2, sprIng 2016• CanadIan onCology nursIng Journal reVue
CanadIenne de soIns InfIrmIers en onCologIe survival for patients with CLL, in the absence …